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Introduction
The intensive care unit (ICU) is the epitome of resource-
intensive health care settings. Critically ill patients are more
numerous and more severely ill than ever before, and the
demands upon resources for their care are commensurate.
Integral to the care of these patients is appropriate physio-
logic monitoring, because it is more efficient to prevent
morbidity or treat it at an early stage than to undertake a
major resuscitation or other intervention for the full manifesta-
tions of a serious complication. Monitoring of blood flow,
acid–base status, oxygen transport, coagulation, visceral
organ function, and the development of nosocomial infection
are a few of many aspects of the surveillance of such
patients. Collection of blood for testing is an essential part of
the monitoring of these patients, but it is increasingly recog-
nized that excessive blood testing occurs, leading (only
somewhat facetiously) to an ‘anemia of chronic investigation’.
Cost and quality are inextricably linked, and can be defined in
an optimal relation. Expenditure of additional resources
decreases quality if there is no benefit to the patient.
Increased ease of blood sampling occasioned by invasive
monitoring catheters does not equate with expanded indica-
tions for blood testing. Blood removed from a critically ill
patient for testing can average more than 70 ml/day for days
or even weeks, depending on the nature and the severity of
the illness [1]. The presence of an arterial catheter may
increase blood testing by as much as one third [2]. Waste of
blood occurs each time a catheter is aspirated and flushed
[3], and the risk for nosocomial infection is increased both by
catheter manipulation [4] and by transfusion of allogeneic
packed red blood cell concentrates [5].
Avoidance of needless blood testing thus has both patient
care and economic benefits. Several strategies can be
employed to reduce blood testing while preserving optimal
patient care, including noninvasive hemodynamic monitoring,
adoption of practice parameters for diagnostic evaluation,
and point-of-care (POC) testing. Equally important is the
need for education to change attitudes toward blood testing.
During residency training, a traditional hallmark of efficiency
was to ‘have all the data’; woe unto the house officer who did
not have results available on demand. However, physicians
and surgeons are trained to make decisions and intervene
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The quality and economy of critical care could both be improved if blood losses due to phlebotomy and
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effectively based on incomplete data, and should be comfort-
able obtaining data as dictated by the clinical situation.
Several studies [6,7] demonstrate the lack of utility of routine
preoperative blood testing. Studies performed in the surgical
ICU at the author’s institution demonstrated that blood
testing can be reduced by at least 50% without an adverse
effect on patient care [8,9]. To the extent that attitudes and
expectations must be adjusted, the adjustment process has
been termed ‘learning to not know’ [8].
Noninvasive hemodynamic monitoring
The morbidity of invasive hemodynamic monitoring is
substantial, including infection, vascular injury and other
access-related complications, and inappropriate therapy as a
result of poor quality control or misinterpretation of the data.
Pulmonary artery catheterization is employed less frequently
now as compared with as recently as 5 years ago, owing to
increasing reliance on echocardiography and esophageal
Doppler estimates of aortic blood flow, and to evidence that
use of pulmonary artery catheters may be associated with
increased mortality [10]. Noninvasive measurement of arterial
blood pressure is accurate and the technology is widely avail-
able. New antihypertensive agents such as fenoldopam allow
control of elevated blood pressure without the use of an
indwelling catheter, even in emergencies [11].
Practice parameters for diagnostic evaluation
Practice parameters, sometimes referred to as guidelines, are
increasingly recognized as valuable tools in medical practice.
Far from being ‘cookbook medicine’ or ‘a roadmap for the
malpractice lawyers’, these documents can be very informa-
tive, especially when they are evidence based rather than
relying solely on expert opinion. Available evidence is graded
for quality, recommendations are made based on the quality
of the evidence, and areas where more data are needed
become readily apparent. Practitioners should partner with
their institutions to determine how published documents may
be used to enhance care in the context of local patterns of
practice.
One example relevant to the issue of reduced blood testing in
the ICU is the practice parameter for the evaluation of fever in
critically ill adults published jointly by the Society of Critical
Care Medicine and the Infectious Diseases Society of
America, with the endorsement of the Surgical Infection
Society [12]. The yield of ‘fever work-ups’ in general, and
blood cultures in particular, is very low in the early postopera-
tive period (<72 hours), and therefore evaluation is usually
not indicated. Most of these episodes of fever are either non-
infectious in origin or related to the diagnosed disease
process that necessitated surgery in the first place.
Point-of-care testing
Point-of-care testing of blood samples occurs at or near the
bedside. Initially slow to be accepted, largely because of reg-
ulatory concerns regarding quality control of the data, POC
testing is now recognized to be accurate and to confer
numerous advantages. Turnaround time is reduced, enhanc-
ing clinical care and reducing repetitive tests sent in frustra-
tion over the slow return of results from the initial sample sent
to the main laboratory. Very small (i.e. microliter) blood
samples are required, and in some cases are not even
removed from the patient because indwelling sensors or a
closed circuit extracorporeal sampling device is employed to
permit return of the sample to the patient after analysis.
Perhaps the most prevalent example of POC testing is
glucose monitoring [13], whereas the intracorporeal and
closed circuit extracorporeal technologies are rare by
comparison. Expected error tolerances for bedside glucose
monitoring are ±15%. In a paired study of 247 critically ill
patients, 91–100% of bedside results were within the error
tolerances compared with several reference laboratory ana-
lyzers. There was no impact of abnormal blood gas variables
on the glucose results, but abnormal hematocrit values were
associated with the variant results. Low hematocrit was associ-
ated with an overestimated bedside blood glucose concentra-
tion, whereas the converse was also true [13]. Blood gases and
electrolyte concentrations can also be analyzed at the bedside
with good precision across a range of concentrations for each
analyte. In a recent comparison trial [14], precision studies per-
formed at three different concentrations for each analyte demon-
strated an intra-assay coefficient of variation of 2.5% or less and
an interassay precision of 4% or less in all tests.
The value of POC testing has been demonstrated in the
setting of trauma resuscitation. In a prospective study of 200
patients with major trauma [15], physicians were queried
using a standardized set of questions as to their diagnostic
and therapeutic management plan before and after a battery
of POC tests (hemoglobin, electrolytes, glucose, blood gases
and pH, base deficit, and lactate) became available. Although
electrolytes and blood urea nitrogen never influenced man-
agement, each of the other tests had an impact in 6% of
cases. As would be expected, POC hemoglobin and blood
gas testing were most likely to influence management within
the ensuing 30 min after test results became available.
Conclusion
Blood testing in the ICU is often excessive and unnecessary,
may increase the risk for infection, and may lead to increased
cost. Conservation of blood may be achieved by adhering to
evidence-based guidelines, employing POC testing at the
bedside, and by reducing needless blood testing, and
increasingly is a part of quality patient care in the ICU.
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